3993:HKEXCMOC Group Limited Class H Analysis
Data as of 2026-06-13 - not real-time
¥2,625.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
PKSHA Technology is trading well below its DCF-derived fair value of ¥4,846, with the market price around ¥2,625, implying an upside of roughly 37%. The stock sits under all three moving averages (20‑day, 50‑day, 200‑day) and the 200‑day SMA sits near ¥3,344, underscoring a bearish technical backdrop. Momentum indicators are mixed: the RSI at 39 hints at potential oversold conditions, yet the MACD histogram remains negative, confirming bearish momentum. Fundamentally, the company posted an impressive 89% revenue growth year‑over‑year and maintains a solid gross margin of about 49% and operating margin near 19%. The balance sheet shows a moderate debt‑to‑equity ratio of 21% and ample cash reserves exceeding ¥15.8 bn, supporting financial flexibility. Volatility is high at roughly 70% over the past 30 days, and historical drawdowns have reached ‑41%, suggesting price swings can be sharp.
Given the substantial valuation gap and strong growth fundamentals, the stock presents a compelling long‑run thesis, but short‑term traders should respect the current bearish technical signals and tight support around ¥2,586. The absence of a dividend eliminates income considerations, placing the emphasis squarely on capital appreciation. While the tech‑infrastructure sector carries inherent cyclical and regulatory uncertainties, PKSHA’s diversified AI‑driven product suite across retail, automotive, finance, and healthcare provides a buffer against sector‑specific headwinds. Overall, the combination of undervaluation, robust earnings outlook, and solid cash position favours a buy stance for investors with a medium to long horizon, while short‑term positioning calls for caution.
Given the substantial valuation gap and strong growth fundamentals, the stock presents a compelling long‑run thesis, but short‑term traders should respect the current bearish technical signals and tight support around ¥2,586. The absence of a dividend eliminates income considerations, placing the emphasis squarely on capital appreciation. While the tech‑infrastructure sector carries inherent cyclical and regulatory uncertainties, PKSHA’s diversified AI‑driven product suite across retail, automotive, finance, and healthcare provides a buffer against sector‑specific headwinds. Overall, the combination of undervaluation, robust earnings outlook, and solid cash position favours a buy stance for investors with a medium to long horizon, while short‑term positioning calls for caution.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below key moving averages
- Negative MACD histogram
- Support level near current price
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation upside
- Strong revenue growth and margins
- Robust cash position vs modest debt
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Diversified AI product portfolio
- Undervalued relative to DCF fair value
- Sustainable earnings expansion potential
Key Metrics & Analysis
Financial Health
Revenue Growth89.10%
Profit Margin7.95%
P/E Ratio33.3
ROE7.16%
ROA4.75%
Debt/Equity21.13
P/B Ratio2.3
Op. Cash Flow¥5.6B
Free Cash Flow¥3.9B
Industry P/E36.8
Technical Analysis
TrendBearish
RSI39.0
Support¥2,586.00
Resistance¥3,310.00
MA 20¥2,847.10
MA 50¥2,994.58
MA 200¥3,344.34
MACDBearish
VolumeStable
Fear & Greed Index89.86
Valuation
Fair Value¥4,846.17
Target Price¥3,600.00
Upside/Downside37.14%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.94
Volatility69.54%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.